期刊文献+

老年肾移植术后糖皮质激素冲击所致骨质疏松的危险因素分析 被引量:1

Analysis of risk factors for osteoporosis induced by glucocorticoid after renal transplantation in elderly patients
下载PDF
导出
摘要 目的探讨老年肾移植术后糖皮质激素冲击所致骨质疏松患者的血清氧化应激指标变化及危险因素。方法选取2015年2月至2017年2月郑州市第七人民医院收治的老年肾移植术后糖皮质激素冲击所致骨质疏松患者43例作为观察组,收集同期21例经肾移植术后未发生骨质疏松的老年人作为对照组,观察两组患者骨密度、血清氧化应激、炎症因子等指标变化,并分析骨密度同血清氧化应激、炎症因子之间相关性以及影响骨质疏松发生的危险因素。结果观察组骨密度水平低于对照组,差异具有统计学意义(P <0. 05);观察组晚期氧化蛋白产物(AOPP)、丙二醛(MDA)高于对照组,超氧化物歧化酶(SOD)、总抗氧化能力(TAC)低于对照组,差异具有统计学意义(P <0. 05);观察组C-反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)高于对照组,差异具有统计学意义(P <0. 05); Pearson相关分析显示骨密度与SOD、TAC呈正相关(r=0. 531,0. 474),与AOPP、MDA、CRP、TNF-α、IL-6呈负相关(r=-0. 592,-0. 486,-0. 327,-0. 421,-0. 307,均P <0. 05); logistic回归分析显示年龄、AOPP、MDA、TAC是影响骨质疏松发生的危险因素(P均<0. 05)。结论老年肾移植术后糖皮质激素冲击所致骨质疏松患者的骨密度与AOPP、CRP、TNF-α、IL-6呈负相关,且年龄、AOPP、MDA、TAC均是影响骨质疏松发生的危险因素。 Objective To analys is risk factors in elderly patients with osteoporosis induced by glucocorticoid impact after renal transplantation. Methods Forty-three elderly patients with osteoporosis after renal transplantation treated in Zhengzhou Seventh People’s Hospital from Feb 2015 to Feb 2017 were selected as observation group, meanwhile, 21 elderly patients without osteoporosis after renal transplantation were recruited as control group. The changes of bone density, serum oxidative stress indexes and inflammatory factors in two groups were observed, and the correlations between bone density with serum oxidative stress, inflammatory factors and the risk factors of osteoporosis were also analyzed. Results The bone density level in observation group was significantly lower than that in control group ( P 〈0.05); the levels of advanced oxidation protein products (AOPP) and malondialdehyde (MDA) in observation group were significantly higher than those in control group, superoxide dismutase (SOD) and total antioxidant capacity (TAC) were significantly lower than those in control group, and the differences were statistically significant ( P 〈0.05); the C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in observation group were significantly higher than those in control group, and the differences were statistically significant ( P 〈 0.05). Pearson correlation analysis showed that BMD was positively correlated with SOD and TAC ( r =0.531/0.474) and negatively correlated with AOPP, MDA, CRP, TNF-α and IL-6 (-0.592/-0.486/-0.327/-0.421/-0.307, all P 〈0.05). Logistic regression analysis showed age, AOPP, MDA, SOD, TAC, CRP, TNF-α and IL-6 were risk factors for osteoporosis ( P 〈0.05). Conclusion Bone mineral density is negatively correlated with AOPP, CRP, TNF-α and IL-6 in elderly patients with osteoporosis induced by glucocorticoid shock after renal transplantation, and age, AOPP, MDA, SOD, TAC, CRP, TNF-α and IL-6 are all risk factors of osteoporosis.
作者 韩健乐 张靖华 HAN Jianle;ZHANG Jinghua(Department of Nephrology,Zhengzhou Seventh People's Hospital,Zhengzhou 45000,China)
出处 《安徽医学》 2018年第11期1356-1359,共4页 Anhui Medical Journal
关键词 肾移植 糖皮质激素 骨质疏松 氧化应激 炎症因子 Renal transplantation Glucocorticoid Osteoporosis Oxidative stress Inflammatory factors
  • 相关文献

参考文献12

二级参考文献91

  • 1张智海,沈建雄,刘忠厚.中国人骨质疏松症诊断标准回顾性研究[J].中国骨质疏松杂志,2004,10(3):255-262. 被引量:110
  • 2张智海,刘忠厚.周围型双能X线骨密度仪(pDEXA)诊断技术[J].中国骨质疏松杂志,2006,12(4):409-414. 被引量:17
  • 3VAN STAA T P, LEUFKENS H G, ABENHAIM L, et al. Use of oral corticosteroids and risk of fractures [ J ]. J Bone Miner Res, 2000,15 (6) :993 - 1000.
  • 4GROSSMAN J M, GORDON R, RANGANATH V K, et al. Ameri- can College of Rheumatology 2010 recommendations for the preven- tion and treatment of glucocorticoid induced - osteoporosis [ J ]. Arthritis Care Res, 2010, 62( 11 ) : 1515 - 1526.
  • 5LEKAWASAM S, ADACHI J D, AGNUSDEI D, et al. For the Joint IOF- ECTS GIO Guidelines Working Group (2012). A framework for the development of guidelines for the management of glucocorticoid -induced osteoporosis [J]. Osteoporos Int, 2012, 23(9): 2257- 2276.
  • 6SAAG K G, SHANE E, BOONEN S, et al. Teriparatide or alendr- onate in glucocorticoid - induced osteoporosis [ J]. N Engl J Med, 2007,357(20) :2028 -2039.
  • 7Matuszewska A, Szechifiski J. Mechanisms of osteoporosisdevelopment in patients with rheumatoid arthritis. Postepy HigMed Dosw,2014,68(4) :145-52.
  • 8Chinese Rheumatology Association. The guideline of diagnosisand treatment of Rheumatoid arthritis. Chinese Journal ofRheumatology, 2010 ,14(4) :265-270.
  • 9Heidari B,Hassanjani Roushan MR. Rheumatoid arthritis andosteoporosis. Caspian J Intern Med, 2012,3(3) :445-6.
  • 10Momohara S, Okamoto H, Yago T, et al. The study of bonemineral density and bone turnover markers in postmenopausalwomen with active rheumatoid arthritis. Mod Rheumatol, 2005 ,15(6) :4104.

共引文献1238

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部